Sysmex Co. (OTCMKTS:SSMXY – Get Rating) was the recipient of a significant drop in short interest in January. As of January 31st, there was short interest totalling 12,700 shares, a drop of 68.8% from the January 15th total of 40,700 shares. Based on an average daily volume of 47,500 shares, the short-interest ratio is currently 0.3 days.
Sysmex Stock Performance
Shares of SSMXY traded down $0.96 during trading hours on Friday, hitting $32.50. The company's stock had a trading volume of 11,659 shares, compared to its average volume of 19,857. The company has a market cap of $13.63 billion, a price-to-earnings ratio of 36.93 and a beta of 0.64. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.88 and a quick ratio of 2.07. The business has a 50 day simple moving average of $31.61 and a two-hundred day simple moving average of $30.17. Sysmex has a 52-week low of $25.08 and a 52-week high of $47.57.
Get
Sysmex alerts:
Sysmex (OTCMKTS:SSMXY – Get Rating) last posted its earnings results on Wednesday, November 9th. The company reported $0.28 earnings per share for the quarter. The firm had revenue of $782.19 million during the quarter. Sysmex had a net margin of 11.70% and a return on equity of 12.51%. On average, equities analysts expect that Sysmex will post 0.92 earnings per share for the current fiscal year.
About Sysmex
(Get Rating)
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing.
Featured Articles
- Get a free copy of the StockNews.com research report on Sysmex (SSMXY)
- MarketBeat Week in Review – 2/6 – 2/10
- Will Snowflake Have Tough Sledding, Trying To Keep Rally Alive?
- The Bottom Is In For Cloudflare Stock
- 3 Tickers Leading a Meme Stock Revival
- Microsoft-Activision Blizzard Merger: Navigating Risk and Reward
Receive News & Ratings for Sysmex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sysmex and related companies with MarketBeat.com's FREE daily email newsletter.
Sysmex Co.(場外交易代碼：SSMXY-GET Rating)是1月份空頭股數價格大幅下降的接收方。截至1月31日，空頭股數共有12,700股，較1月15日的40,700股下降了68.8%。以日均成交量47,500股計算，目前短息比率為0.3天。
Sysmex股票表現
SSMXY的股價在週五的交易時段下跌了0.96美元，觸及32.50美元。該公司股票的成交量為11,659股，而其平均成交量為19,857股。該公司市值為136.3億美元，本益比為36.93倍，貝塔係數為0.64。該公司的債務權益比為0.05，流動比率為2.88，速動比率為2.07。該業務的50日簡單移動均線切入位在31.61美元，200日簡單移動均線切入位在30.17美元。Sysmex的52周低點為25.08美元，52周高點為47.57美元。
到達
Sysmex警報：
Sysmex(OTCMKTS：SSMXY-GET Rating)最近一次公佈收益業績是在11月9日星期三。該公司公佈本季度每股收益為0.28美元。該公司本季度的收入為7.8219億美元。Sysmex的淨利潤率為11.70%，股本回報率為12.51%。股票分析師平均預計，Sysmex本財年的每股收益將為0.92美元。
關於Sysmex
(獲取評級)
Sysmex Corp.從事醫療保健業務。它開發、製造、銷售、出口和進口診斷儀器、試劑。以及用於體外診斷的軟體。它還提供血液、尿液和其他標本的臨床實驗室檢測。其產品包括止血、免疫化學、臨床化學、尿液分析和護理點(POC)測試的儀器和試劑診斷。
專題文章
- 免費獲取關於Sysmex(SSMXY)的StockNews.com研究報告
- 市場回顧周-2/6/2/10
- 為了讓拉力活下去，雪花會有艱難的雪橇嗎？
- Cloudflare股票的底部已經到來
- 引領Meme股票復甦的3個股票代碼
- 微軟與動視暴雪合併：駕馭風險與回報
接受Sysmex Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Sysmex和相關公司的最新新聞和分析師評級的每日簡要摘要。
